RPT-UPDATE 1-Biotech firm Galapagos says GSK stops joint drug project
* GSK stops project in ulcerative colitis and psoriasis * Galapagos' main drug based on similar technology * Shares fall to two-year low (Repeats to additional subscribers) BRUSSELS, Aug 8 (Reuters) - Belgian biotech group Galapagos said its partner GlaxoSmithKline had stoppe
Read more